Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 2
This study is comparing FOLFOX-A chemotherapy with AG chemotherapy for pancreatic cancer. It is for people who are suitable to have surgery to remove the cancer.
The PRIMUS 002 study is part of a larger research programme looking at new treatments for cancer of the pancreas. To take part in Primus 002, you must have already joined a study called Precision-Panc. In this study, your doctor looked at the make up of your cancer and they have now matched you to have the treatment in this study.
Cancer Research UK supports this study.
Recruitment start: 5 April 2019
Recruitment end: 19 August 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Derek Grose
Cancer Research UK
Cancer Research UK Clinical Trials Unit, Glasgow
NHS Greater Glasgow and Clyde
Celgene
Last reviewed: 14 January 2022
CRUK internal database number: 15220
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
